Deakin JO'Loughlin C (2008) STAR*D: a summary and UK perspective. J Psychopharm23: 605-612.
2.
McAllister-Williams RH (2008) Misinterpretation of randomized trial evidence: do antidepressants work? Br J Hosp Med (Lond)69: 246-247.
3.
McGrath PJStewart JWFava MTrivedi MHWisniewski SRNierenberg AA (2006) Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry163: 1531-1541.
4.
Rush AJTrivedi MHWisniewski SRNierenberg AAStewart JWWarden D (2006a) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry163: 1905-1917.
5.
Rush AJTrivedi MHWisniewski SRStewart JWNierenberg AAThase ME (2006b) Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med354: 1231-1242.
6.
Scott JColom FVieta E (2007) A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol10: 123-129.
7.
Scott JPaykel EMorriss RBentall RKinderman PJohnson T (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry188: 313-320.
8.
Thase ME (2002) Studying new antidepressants: if there were a light at the end of the tunnel, could we see it? J Clin Psychiatry63 (Suppl. 2): 24-28.
9.
Trivedi MHFava MWisniewski SRThase MEQuitkin FWarden D (2006a) Medication augmentation after the failure of SSRIs for depression. N Engl J Med354: 1243-1252.
10.
Trivedi MHRush AJWisniewski SRNierenberg AAWarden DRitz L (2006b) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry163: 28-40.
11.
Zetin MHoepner CT (2007) Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol27: 295-301.